Home » Topics » Regulatory

Regulatory
RSS

FDA approves GSK's raxibacumab for inhalational anthrax

Dec. 17, 2012

FDA expands indication for Zytiga

Dec. 12, 2012

FDA approves Cometriq, EMA accepts MAA

Nov. 30, 2012

FDA approves Zilver PTX drug-eluting stent for peripheral arterial disease

Nov. 16, 2012

Bristol-Myers Squibb and AstraZeneca gain European approval for dapagliflozin

Nov. 15, 2012

FDA approves Pfizer's Xeljanz for rheumatoid arthritis

Nov. 8, 2012

Glybera gene therapy approved by the European Commission

Nov. 5, 2012

FDA grants first approval to ocriplasmin

Oct. 18, 2012

FDA approves Abraxane for NSCLC

Oct. 15, 2012

FDA approves Cystaran for corneal cystine crystals

Oct. 5, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....